期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons 被引量:8
1
作者 Wei-Tao Yan Wen-Juan Zhao +5 位作者 Xi-Min Hu Xiao-Xia Ban Wen-Ya Ning Hao Wan Qi Zhang Kun Xiong 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第2期357-363,共7页
PANoptosis is a newly identified type of regulated cell death that consists of pyroptosis,apoptosis,and nec roptosis,which simultaneously occur during the pathophysiological process of infectious and inflammatory dise... PANoptosis is a newly identified type of regulated cell death that consists of pyroptosis,apoptosis,and nec roptosis,which simultaneously occur during the pathophysiological process of infectious and inflammatory diseases.Although our previous lite rature mining study suggested that PANoptosis might occur in neuronal ischemia/repe rfusion injury,little experimental research has been reported on the existence of PANoptosis.In this study,we used in vivo and in vitro retinal neuronal models of ischemia/repe rfusion injury to investigate whether PAN optosis-like cell death(simultaneous occurrence of pyroptosis,apo ptosis,and necroptosis)exists in retinal neuronal ischemia/repe rfusion injury.Our results showed that ischemia/repe rfusion injury induced changes in morphological features and protein levels that indicate PANoptosis-like cell death in retinal neurons both in vitro and in vivo.Ischemia/repe rfusion inju ry also significantly upregulated caspase-1,caspase-8,and NLRP3 expression,which are important components of the PANoptosome.These results indicate the existence of PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons and provide preliminary experimental evidence for future study of this new type of regulated cell death. 展开更多
关键词 apoptosis gasdermin-D(GSDMD) ISCHEMIA/REPERFUSION mixed lineage kinase domain-like protein(MLKL) NECROPTOSIS nod-like receptor protein 3(nlrp3) PANoptosis PYROPTOSIS receptor-interacting protein kinase 3(RIPK3) retinal neuron
下载PDF
当归补血汤及其活性成分通过抑制NLRP3炎症小体活化改善糖尿病肾病的实验研究 被引量:13
2
作者 朱景天 王文恺 +3 位作者 葛凡 孙悦 李子航 薛梅 《中药药理与临床》 CAS CSCD 北大核心 2022年第1期31-35,共5页
目的:探究不同剂量的当归补血汤及其活性成分黄芪甲苷改善糖尿病肾病的作用机制及与NOD样受体蛋白3(nod-like receptor protein 3,NLRP3)炎症小体的相关性。方法:5 w~8 w的雄性GK大鼠分为模型对照组、阳性药格列喹酮10 mg/kg、盐酸贝那... 目的:探究不同剂量的当归补血汤及其活性成分黄芪甲苷改善糖尿病肾病的作用机制及与NOD样受体蛋白3(nod-like receptor protein 3,NLRP3)炎症小体的相关性。方法:5 w~8 w的雄性GK大鼠分为模型对照组、阳性药格列喹酮10 mg/kg、盐酸贝那普利片10 mg/kg、当归补血汤2、4、8 g/kg组、黄芪甲苷40 mg/kg组,每组10只;10只雄性Wistar大鼠作为正常对照组。各组灌胃相应药物,正常对照组和模型对照组灌胃生理盐水,连续8 w。检测随机血糖、空腹血糖;计算肾脏系数;Elisa法检测大鼠尿液中白蛋白含量;HE染色观察肾脏组织病理改变;Western Blot法检测大鼠肾脏NLRP3、ASC、Caspase-1蛋白的表达。结果:与正常对照组相比,模型对照组大鼠的血糖、肾脏系数、尿白蛋白含量、炎症蛋白表达量均显著升高(P<0.01);与模型对照组比较,当归补血汤4、8 g/kg及其活性成分黄芪甲苷0.04 g/kg均可改善GK大鼠的体质量、血糖、肾脏肥大的情况,显著降低尿白蛋白含量,能有效抑制NLRP3小体的活化,其中8 g/kg组对调节血糖、降低尿白蛋白含量效果最为显著(P<0.01)。结论:不同剂量当归补血汤及其活性成分黄芪甲苷对GK大鼠肾脏均具有一定的保护作用,其机制与抑制NLRP3炎症小体密切相关。 展开更多
关键词 当归补血汤 糖尿病肾病 黄芪甲苷 NOD样受体蛋白3(nod-like receptor protein 3 nlrp3)炎症小体
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部